US equities
|
NVDA
$162.85
▼-2.01%
AMD
$534.06
▼-8.75%
MU
$778.31
▼-2.52%
AAPL
$356.27
▲+0.39%
MSFT
$523.88
▲+0.17%
TSLA
$390.22
▼-1.82%
AVGO
$347.01
▼-4.76%
SNDK
$885.01
▼-5.59%
NVDA
$162.85
▼-2.01%
AMD
$534.06
▼-8.75%
MU
$778.31
▼-2.52%
AAPL
$356.27
▲+0.39%
MSFT
$523.88
▲+0.17%
TSLA
$390.22
▼-1.82%
AVGO
$347.01
▼-4.76%
SNDK
$885.01
▼-5.59%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
State Street SPDR S&P Pharmaceuticals ETF
(NY:
XPH
)
66.83
-0.19 (-0.28%)
Official Closing Price
Updated: 8:00 PM EST, Nov 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about State Street SPDR S&P Pharmaceuticals ETF
AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
July 26, 2024
AstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.
Via
MarketBeat
Topics
ETFs
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
September 01, 2023
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
Via
MarketBeat
Topics
Economy
